Analyst Ratings for Halozyme Therapeutics (halo)
halo Rating Summary
halo Price Target Summary
- Highest: $130.00 (H.C. Wainwright)
- Lowest: $58.00 (Goldman Sachs)
- Average: $97.44
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$97.44 (-21.8%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
Avg. $ Target:
$97.44 (-21.8%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Leerink | David Risinger | Upgrade | Outperform (Market Perform) |
110.00 (83.00) |
85.76 (124.54) |
45.22% | Details |
| 5/20/2026 | JPMorgan » Updated 10/8/2026 |
Jessica Fye | New Coverage | Neutral (N/A) |
78.00 (70.00) |
67.44 (124.54) |
84.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
